The American Society of Hematology (ASH) recently named Simon Maddock, MD Class of 2024, as one of this year’s HONORS Award recipients.
The Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award aims to support talented medical students and residents who are interested in hematology but have not yet entered a hematology-related training program.
“I am very grateful to be a recipient of the ASH HONORS Award,” says Mr. Maddock, one of 37 medical students to receive the award in 2021. “This award allows me to continue the pursuit of my goals of treating individuals with hematologic disorders and advancing hematologic therapies through research.”
Recipients receive $5,000 to conduct hematology research projects. Each HONORS participant will have an ASH research mentor who will assist and oversee the awardee’s work and progress.
“My summer research experience in Dr. Donald Kohn's lab at UCLA furthered the development of a gene therapy for alpha thalassemia with his guidance and support,” Mr. Maddock says. “It is a privilege to be able to work with other institutions in advancing therapies during my medical training at EVMS.”
ASH is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment and prevention of disorders affecting the blood.
“We are committed to maintaining a strong hematology workforce, and that begins with ensuring we are recruiting talented and passionate scientists at this early stage of their careers,” says 2021 ASH President Martin S. Tallman, MD, of Memorial Sloan Kettering Cancer Center. “Congratulations to the awardees as they navigate the exciting opportunities available to them in hematology with research funding and mentor support through the ASH HONORS award.”